BioMarin Pharmaceutical (NASDAQ:BMRN) Earns “Sector Perform” Rating from Royal Bank of Canada
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank of Canada in a note issued to investors on Wednesday, Benzinga reports. They currently have a $80.00 target price on the biotechnology company’s stock. Royal Bank of Canada’s price objective indicates a potential upside of […]
More Stories
ReGen III (CVE:GIII) Trading Down 2.7% – Here’s Why
ReGen III Corp. (CVE:GIII – Get Free Report)’s share price dropped 2.7% on Monday . The stock traded as low...
GB Group (OTCMKTS:GBGPF) Trading Down 8.4% – Time to Sell?
GB Group plc (OTCMKTS:GBGPF – Get Free Report)’s share price dropped 8.4% during mid-day trading on Monday . The company...
Innovus Pharmaceuticals (OTCMKTS:INNVD) Stock Price Up 143.9% – Here’s Why
Shares of Innovus Pharmaceuticals Inc (OTCMKTS:INNVD – Get Free Report) rose 143.9% on Monday . The stock traded as high...
Nomad Foods Limited (NYSE:NOMD) Declares $0.15 Quarterly Dividend
Nomad Foods Limited (NYSE:NOMD – Get Free Report) declared a quarterly dividend on Tuesday, October 29th, NASDAQ reports. Investors of...
First Real Estate Investment Trust of New Jersey, Inc. Announces Dividend of $0.58 (OTCMKTS:FREVS)
First Real Estate Investment Trust of New Jersey, Inc. (OTCMKTS:FREVS – Get Free Report) announced a dividend on Monday, October...
Bank of Hawaii Co. (NYSE:BOH) Insider Sells $97,925.85 in Stock
Bank of Hawaii Co. (NYSE:BOH – Get Free Report) insider Matthew Emerson sold 1,355 shares of the stock in a...